Anti-VEGF Therapy and the Retina: An Update
作者： Vikas Tah , Harry O. Orlans , Jonathan Hyer , Edward Casswell , Nizar Din
DOI: 10.1155/2015/627674
关键词: Macular oedema 、 Ophthalmology 、 Occlusion 、 Retina 、 Diabetic macular oedema 、 Disease 、 Retinal Vein 、 Retinal 、 Anti vegf 、 Medicine
摘要: Ocular angiogenesis and macular oedema are major causes of sight loss across the world. Aberrant neovascularisation, which may arise secondary to numerous disease processes, can result in reduced vision as a oedema, haemorrhage, scarring. The development antivascular endothelial growth factor (anti-VEGF) agents has revolutionised treatment retinal vasogenic conditions. These drugs now commonly employed for plethora ocular pathologies including choroidal diabetic vein occlusion name few. In this paper, we will explore current use anti-VEGF variety diseases impact that these medications have had on visual outcome patients.
hindawi.com
core.ac.uk参考文章(81)
Michael J Elman, Neil M Bressler, Haijing Qin, Roy W Beck, Frederick L Ferris III, Scott M Friedman, Adam R Glassman, Ingrid U Scott, Cynthia R Stockdale, Jennifer K Sun, Diabetic Retinopathy Clinical Research Network, Writing Committee, None, Expanded 2-Year Follow-up of Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema Ophthalmology. ,vol. 118, pp. 609- 614 ,(2011) , 10.1016/J.OPHTHA.2010.12.033
Hsin-Yu Yao, Chi-Ting Horng, Jiann-Torng Chen, Ming-Ling Tsai, Regression of choroidal metastasis secondary to breast carcinoma with adjuvant intravitreal injection of bevacizumab. Acta Ophthalmologica. ,vol. 88, ,(2010) , 10.1111/J.1755-3768.2009.01684.X
Jonathan B. Gunther, Michael M. Altaweel, Bevacizumab (Avastin) for the treatment of ocular disease. Survey of Ophthalmology. ,vol. 54, pp. 372- 400 ,(2009) , 10.1016/J.SURVOPHTHAL.2009.02.004
Rufino Silva, Myopic maculopathy: a review. Ophthalmologica. ,vol. 228, pp. 197- 213 ,(2012) , 10.1159/000339893
Ben George, William J. Wirostko, Thomas B. Connor, Nicholas W. Choong, Complete and Durable Response of Choroid Metastasis from Non-small Cell Lung Cancer with Systemic Bevacizumab and Chemotherapy Journal of Thoracic Oncology. ,vol. 4, pp. 661- 662 ,(2009) , 10.1097/JTO.0B013E31819C9A73
Brandon G. Busbee, Allen C. Ho, David M. Brown, Jeffrey S. Heier, Ivan J. Suñer, Zhengrong Li, Roman G. Rubio, Phillip Lai, Twelve-month efficacy and safety of 0.5 mg or 2.0 mg ranibizumab in patients with subfoveal neovascular age-related macular degeneration. Ophthalmology. ,vol. 120, pp. 1046- 1056 ,(2013) , 10.1016/J.OPHTHA.2012.10.014
Tien Y. Wong, Alberto Ferreira, Rowena Hughes, Gemma Carter, Paul Mitchell, Epidemiology and Disease Burden of Pathologic Myopia and Myopic Choroidal Neovascularization: An Evidence-Based Systematic Review American Journal of Ophthalmology. ,vol. 157, pp. 9- 25 ,(2014) , 10.1016/J.AJO.2013.08.010
PL Penfold, L Wen, MC Madigan, MC Gillies, NJC King, JM Provis, None, Triamcinolone acetonide modulates permeability and intercellular adhesion molecule-1 (ICAM-1) expression of the ECV304 cell line: implications for macular degeneration. Clinical and Experimental Immunology. ,vol. 121, pp. 458- 465 ,(2000) , 10.1046/J.1365-2249.2000.01316.X
grupo estudio VIEW2 HHO Dominguez, None, Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration. Ophthalmology. ,vol. 119, pp. 2537- 2548 ,(2012) , 10.1016/J.OPHTHA.2012.09.006
Sebastian Wolf, Vilma Jurate Balciuniene, Guna Laganovska, Ugo Menchini, Kyoko Ohno-Matsui, Tarun Sharma, Tien Y Wong, Rufino Silva, Stefan Pilz, Margarita Gekkieva, RADIANCE Study Group, RADIANCE: A Randomized Controlled Study of Ranibizumab in Patients with Choroidal Neovascularization Secondary to Pathologic Myopia Ophthalmology. ,vol. 121, pp. 682- 692 ,(2014) , 10.1016/J.OPHTHA.2013.10.023